Integer Holdings Corporation (ITGR)
NYSE: ITGRHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ITGR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.30B
- P/E (TTM)
- 34.59
- Forward P/E
- 18.43
- EPS (TTM)
- $3.66
- Dividend yield
- None
- 52-week range
- 62.00 – 126.80
- Day range
- 126.50 – 126.63
- Volume / Avg
- 356.69K / 986.14K
- Beta
- —
- Shares outstanding
- 34.00M
- Next earnings
- Oct 22, 2026
52-week range
ITGR stock today
Shares of Integer (ITGR) finished higher on Oct 7 at $126.59, a gain of 0.09% or $0.12 per share, versus the S&P 500's 0.22% decline. Trading was light, with 356.69K shares changing hands, about 36% of the average daily volume. The stock is trading at or near its 52-week high of $126.80, set on Sep 4, 2026, 104.2% above the 52-week low of $62.00.
ITGR is up 61.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 22.0%. Integer trades at 34.6x its trailing twelve-month earnings per share of $3.66. Its forward P/E of 18.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 22; analysts expect EPS of $1.65.
Summary generated from market data by MetaCap's automated system. Methodology
About Integer
Company profileInteger Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Payman Khales
- Headquarters
- Plano, TX
- Employees
- 11,000
- Website
- integer.net
Financial highlights
Full financialsIn fiscal 2025, Integer generated $1.85 billion in revenue, up 8.0% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $102.8 million (-14.3% year over year), for a net margin of 5.5% versus a median of 7.0% in the prior 5 years. Gross margin was 27.0% (up from 26.7%) and operating margin 11.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.85B | $1.72B | $1.56B | $1.33B | $1.22B |
| Growth | +7.98% | +10.35% | +16.85% | +9.02% | +13.75% |
| Net income | $102.81M | $119.90M | $90.65M | $66.38M | $96.81M |
| EPS (diluted) | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 |
Analyst forecast
ForecastConsensus (9 analysts)
none
Avg. price target
$121.80-3.78%
- Strong buy 0
- Buy 0
- Hold 9
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 22, 2026
- EPS estimate
- $1.65
- Last reported (Q2 2026)
- Aug 4, 2026
- EPS actual vs est.
- $0.69 vs —
Integer peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LIVNLivaNova PLC | 75.93 | +1.33% | $4.17B | vs ITGR |
| TMDXTransMedics Group Inc. | 81.07 | +0.98% | $2.81B | vs ITGR |
| AXGNAxogen Inc. | 36.04 | -0.74% | $2.11B | vs ITGR |
| VANIVivani Medical Inc. | 1.27 | +2.42% | $114.56M | vs ITGR |
| STXSStereotaxis Inc. | 1.13 | -1.74% | $113.23M | vs ITGR |
| HYPRHyperfine Inc. Class A | 0.849 | -2.41% | $90.04M | vs ITGR |
| ECORelectroCore Inc. | 9.72 | -2.02% | $87.63M | vs ITGR |
| NRXSNeuraxis Inc. | 6.83 | +0.74% | $85.77M | vs ITGR |
Indexes, lists and sector
Integer stock FAQ
What is Integer's stock price today?
ITGR last traded at $126.59 as of Oct 7, 4:00 PM EDT, up 0.09% on the day. Prices are delayed at least 15 minutes.
When is Integer's next earnings date?
Integer is expected to report earnings on Thursday, October 22, 2026. Analysts expect EPS of $1.65.
What is ITGR's P/E ratio?
ITGR trades at a trailing P/E ratio of 34.59 and a forward P/E of 18.43.
Who is Integer's CEO?
Mr. Payman Khales is the chief executive officer of Integer Holdings Corporation, which has about 11,000 employees.
What is the ITGR 52-week high?
The 52-week high for ITGR is $126.80 and the 52-week low is $62.00. The stock is currently 0.2% below its high.